Cite

Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.

MLA

Cole, Laurence A., et al. “Gestational Trophoblastic Diseases: 2. Hyperglycosylated HCG as a Reliable Marker of Active Neoplasia.” Gynecologic Oncology, vol. 102, no. 2, Aug. 2006, pp. 151–59. EBSCOhost, https://doi.org/10.1016/j.ygyno.2005.12.045.



APA

Cole, L. A., Butler, S. A., Khanlian, S. A., Giddings, A., Muller, C. Y., Seckl, M. J., & Kohorn, E. I. (2006). Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecologic Oncology, 102(2), 151–159. https://doi.org/10.1016/j.ygyno.2005.12.045



Chicago

Cole, Laurence A, Stephen A Butler, Sarah A Khanlian, Almareena Giddings, Carolyn Y Muller, Michael J Seckl, and Ernest I Kohorn. 2006. “Gestational Trophoblastic Diseases: 2. Hyperglycosylated HCG as a Reliable Marker of Active Neoplasia.” Gynecologic Oncology 102 (2): 151–59. doi:10.1016/j.ygyno.2005.12.045.